Setileuton
Setileuton (MK-0633) is an inhibitor for 5-lipoxygenase, that inhibits the oxidation of arachidonic acid by recombinant human 5-LO, and the production of LTB4 in calcium ionophore-stimulated human whole blood, with IC50 of 3.9 and 52 nM, respectively[1].
Product Specifications
CAS Number
[910656-27-8]
Product Name Alternative
MK-0633
UNSPSC
12352005
Target
Lipoxygenase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/setileuton.html
Purity
99.9
Solubility
10 mM in DMSO
Smiles
O=C1C=C(C2=CC=C(C=C2)F)C3=CC=C(CNC4=NN=C([C@](CC)(O)C(F)(F)F)O4)C=C3O1
Molecular Formula
C22H17F4N3O4
Molecular Weight
463.38
References & Citations
[1]Ducharme Y, et al., The discovery of setileuton, a potent and selective 5-lipoxygenase inhibitor. ACS Med Chem Lett. 2010 Apr 13;1 (4) :170-4.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Neisseria meningitidis serogroup B Outer-membrane lipoprotein carrier protein (lolA)
Recombinant Neisseria meningitidis serogroup B Outer-membrane lipoprotein carrier protein (lolA)
Recombinant Neisseria meningitidis serogroup B Outer-membrane lipoprotein carrier protein (lolA)
Recombinant Neisseria meningitidis serogroup B Outer-membrane lipoprotein carrier protein (lolA)
Recombinant Neisseria meningitidis serogroup B Outer-membrane lipoprotein carrier protein (lolA)